Aptus Capital Advisors’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52.5M | Sell |
121,261
-17,107
| -12% | -$5.19M | 0.36% | 62 |
|
|
2026
Q1 | $29.6M | Sell |
138,368
-166,306
| -55% | -$37.2M | 0.23% | 86 |
|
|
2025
Q4 | $52.2M | Buy |
304,674
+3,143
| +1% | +$489K | 0.37% | 57 |
|
|
2025
Q3 | $40.4M | Buy |
301,531
+262,043
| +664% | +$27.7M | 0.29% | 72 |
|
|
2025
Q2 | $3.84M | Sell |
39,488
-10,151
| -20% | -$805K | 0.03% | 325 |
|
|
2025
Q1 | $3.61M | Buy |
49,639
+11,269
| +29% | +$887K | 0.04% | 321 |
|
|
2024
Q4 | $2.78M | Buy |
38,370
+22,120
| +136% | +$1.68M | 0.03% | 347 |
|
|
2024
Q3 | $510K | Buy |
16,250
+580
| +4% | +$50.4K | 0.01% | 533 |
|
|
2024
Q2 | $1.67M | Buy |
15,670
+680
| +5% | +$65.2K | 0.03% | 319 |
|
|
2024
Q1 | $1.46M | Buy |
14,990
+5,140
| +52% | +$452K | 0.03% | 339 |
|
|
2023
Q4 | $772K | Sell |
9,850
-630
| -6% | -$42.9K | 0.02% | 319 |
|
|
2023
Q3 | $657K | Buy |
10,480
+4,820
| +85% | +$317K | 0.02% | 340 |
|
|
2023
Q2 | $364K | Sell |
5,660
-260
| -4% | -$14.7K | 0.01% | 366 |
|
|
2023
Q1 | $315K | Sell |
5,920
-82,820
| -93% | -$4.06M | 0.01% | 385 |
|
|
2022
Q4 | $3.73M | Sell |
88,740
-130,830
| -60% | -$5.47M | 0.11% | 151 |
|
|
2022
Q3 | $8.04M | Sell |
219,570
-3,150
| -1% | -$140K | 0.19% | 72 |
|
|
2022
Q2 | $9.49M | Buy |
222,720
+6,850
| +3% | +$326K | 0.25% | 60 |
|
|
2022
Q1 | $11.6M | Buy |
215,870
+38,170
| +21% | +$2.22M | 0.29% | 47 |
|
|
2021
Q4 | $12.8M | Buy |
177,700
+33,170
| +23% | +$2.08M | 0.38% | 37 |
|
|
2021
Q3 | $8.23M | Buy |
144,530
+11,440
| +9% | +$696K | 0.21% | 58 |
|
|
2021
Q2 | $8.66M | Buy |
133,090
+5,360
| +4% | +$338K | 0.25% | 51 |
|
|
2021
Q1 | $7.6M | Sell |
127,730
-42,720
| -25% | -$2.33M | 0.27% | 52 |
|
|
2020
Q4 | $8.05M | Sell |
170,450
-14,000
| -8% | -$589K | 0.37% | 50 |
|
|
2020
Q3 | $6.12M | Buy |
184,450
+6,940
| +4% | +$239K | 0.32% | 58 |
|
|
2020
Q2 | $5.74M | Sell |
177,510
-2,520
| -1% | -$68.7K | 0.36% | 49 |
|
|
2020
Q1 | $4.32M | Buy |
180,030
+99,320
| +123% | +$2.86M | 0.37% | 52 |
|
|
2019
Q4 | $2.36M | Buy |
80,710
+11,270
| +16% | +$299K | 0.17% | 133 |
|
|
2019
Q3 | $1.6M | Sell |
69,440
-12,030
| -15% | -$253K | 0.09% | 137 |
|
|
2019
Q2 | $1.53M | Sell |
81,470
-37,170
| -31% | -$705K | 0.22% | 85 |
|
|
2019
Q1 | $2.12M | Buy |
118,640
+3,420
| +3% | +$57.1K | 0.36% | 51 |
|
|
2018
Q4 | $1.57M | Buy |
+115,220
| New | +$1.65M | 0.41% | 31 |
|
Other funds holding LRCX
Aptus Capital Advisors's LRCX Position: Q2 2026 in Review
Aptus Capital Advisors reduced its Lam Research (LRCX) stake by 12% in Q2 2026, selling an estimated $5.19M and leaving 121,261 shares worth $52.5M. The position accounts for 0.36% of the portfolio, ranked #62.
Aptus Capital Advisors first reported a position in LRCX in Q4 2018 and has held it in 31 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Aptus Capital Advisors held 121,261 shares of Lam Research worth $52.5M as of Q2 2026.
- Aptus Capital Advisors sold 17,107 Lam Research shares in Q2 2026, an estimated $5.19M.
- Lam Research made up 0.36% of Aptus Capital Advisors's portfolio in Q2 2026, its #62 holding.
- Aptus Capital Advisors first reported a position in Lam Research in Q4 2018 and has held it in 31 quarters since.
- 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.